138 related articles for article (PubMed ID: 37850576)
21. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum.
Deolet E; Arora I; Van Dorpe J; Van der Meulen J; Desai S; Van Roy N; Kaur B; Van de Vijver K; McCluggage WG
Am J Surg Pathol; 2022 Jan; 46(1):124-133. PubMed ID: 34183523
[TBL] [Abstract][Full Text] [Related]
22. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations and their therapeutic implications in epithelial ovarian cancer.
Lapke N; Chen CH; Chang TC; Chao A; Lu YJ; Lai CH; Tan KT; Chen HC; Lu HY; Chen SJ
BMC Cancer; 2021 May; 21(1):499. PubMed ID: 33947352
[TBL] [Abstract][Full Text] [Related]
24. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.
Kim H; Na K; Bae GE; Kim HS
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829389
[TBL] [Abstract][Full Text] [Related]
25. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
26. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
27. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
Mirkovic J; Sholl LM; Garcia E; Lindeman N; MacConaill L; Hirsch M; Dal Cin P; Gorman M; Barletta JA; Nucci MR; McCluggage WG; Howitt BE
Mod Pathol; 2015 Nov; 28(11):1504-14. PubMed ID: 26336887
[TBL] [Abstract][Full Text] [Related]
28. Synchronous ovarian and uterine mesonephric-like carcinoma that potentially arose from endometrioid adenofibroma: A case report.
Ishida K; Ashihara T; So M; Minamiguchi S; Matsumura N; Nonogaki T
J Obstet Gynaecol Res; 2023 Mar; 49(3):1052-1056. PubMed ID: 36597276
[TBL] [Abstract][Full Text] [Related]
29. Histotype-specific copy-number alterations in ovarian cancer.
Huang RY; Chen GB; Matsumura N; Lai HC; Mori S; Li J; Wong MK; Konishi I; Thiery JP; Goh L
BMC Med Genomics; 2012 Oct; 5():47. PubMed ID: 23078675
[TBL] [Abstract][Full Text] [Related]
30. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract][Full Text] [Related]
31. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
[TBL] [Abstract][Full Text] [Related]
32. Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.
D'Angelo E; Espinosa I; Felicioni L; Buttitta F; Prat J
Hum Pathol; 2023 Nov; 141():15-21. PubMed ID: 37673346
[TBL] [Abstract][Full Text] [Related]
33. Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.
Kramer C; Lanjouw L; Ruano D; Ter Elst A; Santandrea G; Solleveld-Westerink N; Werner N; van der Hout AH; de Kroon CD; van Wezel T; Berger L; Jalving M; Wesseling J; Smit V; de Bock GH; van Asperen CJ; Mourits M; Vreeswijk M; Bart J; Bosse T
J Pathol; 2024 Feb; 262(2):137-146. PubMed ID: 37850614
[TBL] [Abstract][Full Text] [Related]
34. An unusual case of carcinoma with mesonephric-like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls.
Besharati S; Liu-Jarin X; Chen X; Cimic A
Diagn Cytopathol; 2022 Nov; 50(11):E325-E329. PubMed ID: 35778908
[TBL] [Abstract][Full Text] [Related]
35. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.
Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
[No Abstract] [Full Text] [Related]
36. Mesonephric-Like Adenocarcinomas a Rare Tumor: The Importance of Diagnosis.
Restaino S; Pellecchia G; Tulisso A; Paglietti C; Orsaria M; Andreetta C; Poletto E; Arcieri M; Martina MD; Biasioli A; Mariuzzi L; Driul L; Scambia G; Vizzielli G
Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361332
[TBL] [Abstract][Full Text] [Related]
37. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
[TBL] [Abstract][Full Text] [Related]
38. [Current WHO classification of the female genitals : Many new things, but also some old].
Mayr D; Schmoeckel E; Höhn AK; Hiller GGR; Horn LC
Pathologe; 2021 May; 42(3):259-269. PubMed ID: 33822250
[TBL] [Abstract][Full Text] [Related]
39. The DNA methylomes of serous borderline tumors reveal subgroups with malignant- or benign-like profiles.
Zeller C; Dai W; Curry E; Siddiq A; Walley A; Masrour N; Kitsou-Mylona I; Anderson G; Ghaem-Maghami S; Brown R; El-Bahrawy M
Am J Pathol; 2013 Mar; 182(3):668-77. PubMed ID: 23357500
[TBL] [Abstract][Full Text] [Related]
40. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
Morency E; Leitao MM; Soslow RA
Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]